切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2021, Vol. 10 ›› Issue (04) : 352 -356. doi: 10.3877/cma.j.issn.2095-3232.2021.04.003

专家论坛

临床胰岛移植:应用及挑战
刘颖1, 陈焕伟1,()   
  1. 1. 528000 广东省佛山市第一人民医院胰腺外科
  • 收稿日期:2021-05-19 出版日期:2021-08-18
  • 通信作者: 陈焕伟
  • 基金资助:
    佛山市建设器官移植技术创新平台(2020A007)

Application and challenges for clinical islets transplantation

Ying Liu1, Huanwei Chen1()   

  • Received:2021-05-19 Published:2021-08-18
  • Corresponding author: Huanwei Chen
引用本文:

刘颖, 陈焕伟. 临床胰岛移植:应用及挑战[J]. 中华肝脏外科手术学电子杂志, 2021, 10(04): 352-356.

Ying Liu, Huanwei Chen. Application and challenges for clinical islets transplantation[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2021, 10(04): 352-356.

[1]
Qi M, Kinzer K, Danielson KK, et al. Five-year follow-up of patients with type 1 diabetes transplanted with allogeneic islets: the UIC experience[J]. Acta Diabetol, 2014, 51(5):833-843.
[2]
Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes[J]. Lancet, 2014, 383(9911):69-82.
[3]
Choudhary P, Geddes J, Freeman JV, et al. Frequency of biochemical hypoglycaemia in adults with type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring[J]. Diabet Med, 2010, 27(6): 666-672.
[4]
Hering BJ, Clarke WR, Bridges ND, et al. Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia[J]. Diabetes Care, 2016, 39(7):1230-1240.
[5]
陈焕伟,栾晓军,刘成洋, 等. 同种异体胰岛细胞移植在成人1型糖尿病中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2020, 9(5):457-461.
[6]
Ballou C, Brindley H, Guan E, et al. Tenth annual report[EB/OL].

URL    
[7]
Lablanche S, Vantyghem MC, Kessler L, et al. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial[J]. Lancet Diabetes Endocrinol, 2018, 6(7): 527-537.
[8]
王树森,崔云峰,王西墨. 慢性胰腺炎全胰切除联合自体胰岛移植指南解读[J/CD]. 实用器官移植电子杂志, 2016, 4(6):321-326.
[9]
Witkowski P, Savari O, Matthews JB. Islet autotransplantation and total pancreatectomy[J]. Adv Surg, 2014(48):223-233.
[10]
Shindo Y, Kanak MA. Total pancreatectomy with islet autotransplantation: recent updates and outcomes[J]. Curr Opin Organ Transplant, 2017, 22(5):444-451.
[11]
陈焕伟,栾晓军,刘成洋, 等. 全胰腺切除联合自体胰岛移植治疗慢性胰腺炎1例报道并文献复习[J]. 器官移植, 2018, 9(6): 451-455.
[12]
Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen[J]. N Engl J Med, 2000, 343(4):230-238.
[13]
Bellin MD, Barton FB, Heitman A, et al. Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes[J]. Am J Transplant, 2012, 12(6): 1576-1583.
[14]
Shapiro AM. State of the art of clinical islet transplantation and novel protocols of immunosuppression[J]. Curr Diab Rep, 2011, 11(5): 345-354.
[15]
Williams J, Jacus N, Kavalackal K, et al. Over ten-year insulin independence following single allogeneic islet transplant without T-cell depleting antibody induction[J]. Islets, 2018, 10(4):168-174.
[16]
Posselt AM, Szot GL, Frassetto LA, et al. Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade[J]. Transplantation, 2010, 90(12):1595-1601.
[17]
Posselt AM, Bellin MD, Tavakol M, et al. Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab[J]. Am J Transplant, 2010, 10(8):1870-1880.
[18]
El Khatib MM, Sakuma T, Tonne JM, et al. β-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection[J]. Gene Ther, 2015, 22(5):430-438.
[19]
Watanabe M, Yamashita K, Suzuki T, et al. ASKP1240, a fully human anti-CD40 monoclonal antibody, prolongs pancreatic islet allograft survival in nonhuman primates[J]. Am J Transplant, 2013, 13(8): 1976-1988.
[20]
Citro A, Cantarelli E, Maffi P, et al. CXCR1/2 inhibition enhances pancreatic islet survival after transplantation[J]. J Clin Invest, 2012, 122(10):3647-3651.
[21]
Kandaswamy R, Skeans MA, Gustafson SK, et al. OPTN/SRTR 2013 annual data report: pancreas[J]. Am J Transplant, 2015, 15 Suppl 2: 1-20.
[22]
Grose S. Critics slam Russian trial to test pig pancreas for diabetics[J]. Nat Med, 2007, 13(4):390-391.
[23]
王维,莫朝辉,叶斌, 等. 新生猪胰岛移植治疗糖尿病病人的临床研究[J]. 中南大学学报(医学版), 2011, 36(12):1134-1140.
[24]
Matsumoto S, Okitsu T, Iwanaga Y, et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation[J]. Lancet, 2005, 365(9471):1642-1644.
[25]
Jung HS, Choi SH, Kim SJ, et al. A better yield of islet cell mass from living pancreatic donors compared with cadaveric donors[J]. Clin Transplant, 2007, 21(6):738-743.
[26]
Hirshberg B. Can we justify living donor islet transplantation?[J]. Curr Diab Rep, 2006, 6(4):307-309.
[27]
Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes[J]. JAMA, 2005, 293(7):830-835.
[28]
Koh A, Senior P, Salam A, et al. Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success[J]. Transplantation, 2010, 89(4): 465-471.
[29]
Shapiro AM. Strategies toward single-donor islets of Langerhans transplantation[J]. Curr Opin Organ Transplant, 2011, 16(6):627-631.
[30]
McCall MD, Toso C, Baetge EE, et al. Are stem cells a cure for diabetes?[J]. Clin Sci, 2009, 118(2):87-97.
[31]
Liu X, Li X, Zhang N, et al. Bioengineering strategies for the treatment of type I diabetes[J]. J Biomed Nanotechnol, 2016, 12(4): 581-601.
[32]
Hrvatin S, O'Donnell CW, Deng F, et al. Differentiated human stem cells resemble fetal, not adult, β cells[J]. Proc Natl Acad Sci U S A, 2014, 111(8):3038-3043.
[33]
Rekittke NE, Ang M, Rawat D, et al. Regenerative therapy of type 1 diabetes mellitus: from pancreatic islet transplantation to mesenchymal stem cells[J]. Stem Cells Int, 2016:3764681.
[34]
Pathak V, Pathak NM, O'Neill CL, et al. Therapies for type 1 diabetes: current scenario and future perspectives[J]. Clin Med Insights Endocrinol Diabetes, 2019(12):117955141984452.
[35]
Potter KJ, Westwell-Roper CY, Klimek-Abercrombie AM, et al. Death and dysfunction of transplanted beta-cells: lessons learned from type 2 diabetes?[J]. Diabetes, 2014, 63(1):12-19.
[36]
Cheng Y, Wang B, Li H, et al. Mechanism for the instant blood-mediated inflammatory reaction in rat islet transplantation[J]. Transplant Proc, 2017, 49(6):1440-1443.
[37]
Samy KP, Davis RP, Gao Q, et al. Early barriers to neonatal porcine islet engraftment in a dual transplant model[J]. Am J Transplant, 2018, 18(4):998-1006.
[38]
Shapiro AM. Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome[J]. Rev Diabet Stud, 2012, 9(4):385-406.
[39]
Sutherland DE, Radosevich DM, Bellin MD, et al. Total pancreatectomy and islet autotransplantation for chronic pancreatitis[J]. J Am Coll Surg, 2012, 214(4):409-424.
[40]
Kanak MA, Takita M, Shahbazov R, et al. Evaluation of microRNA375 as a novel biomarker for graft damage in clinical islet transplantation[J]. Transplantation, 2015, 99(8):1568-1573.
[41]
Yoshimatsu G, Takita M, Kanak MA, et al. MiR-375 and miR-200c as predictive biomarkers of islet isolation and transplantation in total pancreatectomy with islet autotransplantation[J]. J Hepatobiliary Pancreat Sci, 2016, 23(9):585-594.
[42]
Bellin MD, Clark P, Usmani-Brown S, et al. Unmethylated insulin DNA is elevated after total pancreatectomy with islet autotransplantation: assessment of a novel beta cell marker[J]. Am J Transplant, 2017, 17(4):1112-1118.
[43]
Marselli L, Thorne J, Ahn YB, et al. Gene expression of purified beta-cell tissue obtained from human pancreas with laser capture microdissection[J]. J Clin Endocrinol Metab, 2008, 93(3):1046-1053.
[44]
Morgan KA, Lancaster WP, Owczarski SM, et al. Patient selection for total pancreatectomy with islet autotransplantation in the surgical management of chronic pancreatitis[J]. J Am Coll Surg, 2018, 226(4):446-451.
[45]
Wang J, Sun Z, Gou W, et al. α-1 antitrypsin enhances islet engraftment by suppression of instant blood-mediated inflammatory reaction[J]. Diabetes, 2017, 66(4):970-980.
[46]
Citro A, Cantarelli E, Maffi P, et al. CXCR1/2 inhibition enhances pancreatic islet survival after transplantation[J]. J Clin Invest, 2012, 122(10):3647-3651.
[47]
McCall MD, Maciver AM, Kin T, et al. Caspase inhibitor IDN6556 facilitates marginal mass islet engraftment in a porcine islet autotransplant model[J]. Transplantation, 2012, 94(1):30-35.
[1] 何金梅, 尹立雪, 谭静, 张文军, 王锐, 任梅, 廖明娇. 超声心肌做功技术对2型糖尿病患者潜在左心室心肌收缩功能损伤的评价[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1029-1035.
[2] 王珏, 陈赛君, 贲志飞, 詹锦勇, 徐开颖. 剪切波弹性成像联合极速脉搏波技术评估颈动脉弹性对糖尿病性视网膜病变的预测价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 636-641.
[3] 王洁, 丁泊文, 尹健. 糖尿病性乳腺病52例临床分析[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 285-289.
[4] 马敏榕, 李聪, 周勤. 宫颈癌治疗研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 497-504.
[5] 陈絮, 詹玉茹, 王纯华. 孕妇ABO血型联合甲状腺功能检测对预测妊娠期糖尿病的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 604-610.
[6] 张健, 刘小龙, 查天建, 姚俊杰, 王傑. 富含血小板血浆联合异种脱细胞真皮基质修复糖尿病足缺血性创面的临床效果[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 503-506.
[7] 赵雅玫, 谢斌, 陈艳, 吴健. 抗生素骨水泥联合负压封闭引流对糖尿病足溃疡临床疗效的荟萃分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 427-433.
[8] 李琛, 张惟佳, 潘亚萍. 牙周炎与系统性疾病之间关系的应用思考:2022年EFP和WONCA欧洲分部联合研讨会共识报告的解读及启示[J]. 中华口腔医学研究杂志(电子版), 2023, 17(05): 322-327.
[9] 叶弘, 吕婧喆, 钟良军. 白藜芦醇治疗牙周炎和糖尿病的新进展[J]. 中华口腔医学研究杂志(电子版), 2023, 17(05): 376-380.
[10] 巨春蓉, 何建行, 钟南山. 咪唑立宾在器官移植领域的应用及展望[J]. 中华移植杂志(电子版), 2023, 17(04): 227-231.
[11] 孔欣, 宋宝全, 刘吟, 张剑, 仇惠英, 吴德沛. 异基因造血干细胞移植并发难治性呃逆一例[J]. 中华移植杂志(电子版), 2023, 17(04): 253-255.
[12] 黄岩, 刘晓巍, 杨春玲, 兰烨. 急性胰腺炎合并糖尿病患者的临床特征及血糖代谢与病情严重度的相关性[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 439-442.
[13] 张政赢, 鞠阳, 刘晓宁. 二甲双胍对2型糖尿病患者大肠腺瘤术后复发的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 485-488.
[14] 薛念余, 张盛敏, 吴凌恒, 沙蕾, 童揽月, 沈崔琴, 李朝军, 杜联芳. 研究血清胆红素对2型糖尿病患者心脏结构发生改变前心肌功能的影响[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1004-1009.
[15] 谢国晓, 赵凌霞, 薛雪花. 慢性病管理模式在糖尿病社区管理中的应用[J]. 中华临床医师杂志(电子版), 2023, 17(05): 587-590.
阅读次数
全文


摘要